Jan 28, 2020· Comment from Animal Health Institute (AHI)· FDA-2019-D-3361-0004
The ANIMAL HEALTH INSTITUTE (AHI) respectfully submits the following comments on Guidance for Industry #261: Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs.